What happened
OpenAI CEO Sam Altman said he tried the weight loss drug semaglutide before it became widely popular. He also revealed that his busy schedule has led him to neglect his health, including eating junk food and not exercising enough. At one point, Altman was hospitalized after trying semaglutide early on.
Why it matters
- Altman's experience highlights the growing interest and early adoption of semaglutide among influential figures.
- It illustrates challenges busy professionals face in maintaining health despite access to advanced treatments.
- The mention of hospitalization underscores potential risks or side effects associated with early or unsupervised use of semaglutide.
Key facts
- 1. Sam Altman tried semaglutide "before it was cool" and was once hospitalized due to it.
- 2. The article was published 3 hours ago from the current time (November 7, 2025)[source article].
- 3. Altman currently reports eating junk food and exercising insufficiently due to his busy life.
